Reversal of glibenclamide and voltage block of an epithelial KATP channel.
K+ channels present in basolateral membrane vesicles isolated from Necturus maculosa small intestinal cells and reconstituted into planar phospholipid bilayers are inhibited by MgATP and sulfonylurea derivatives, such as tolbutamide and glibenclamide, when these agents are added to the solution bathing the inner mouth of the channel. In addition, these channels possess an intrinsic "voltage gate" and are blocked when the electrical potential difference across the channel is oriented so that the inner solution is electrically positive with respect to the outer solution. We now show that increasing the concentration of permeant ions such as K+ or Rb+ in the outer solution reverses channel inhibition resulting from the addition of 50 microM glibenclamide to the inner solution and also inhibits intrinsic voltage gating; these effects are not elicited by increasing the concentrations of the relatively impermeant ions, Na+ or choline, in the outer solution. Furthermore, increasing the K+ concentration in the outer solution in the absence of glibenclamide inhibits voltage gating, and, under these conditions, the subsequent addition of glibenclamide to the inner solution is ineffective. These results are consistent with a model in which the voltage gate is an open-channel blocker whose action is directly reversed by elevating the external concentration of relatively permeant cations and where the action of glibenclamide is to stabilize the inactivated state of the channel, possibly through hydrophobic interactions.
Mayorga-Wark
O
O
Department of Integrative Biology, University of Texas Medical School, Houston 77030, USA.
Dubinsky
W P
WP
Schultz
S G
SG
D000818:Animals; D002474:Cell-Free System; D002794:Choline / Q000494:pharmacology; D004848:Epithelium / Q000502:physiology; D005905:Glyburide / Q000494:pharmacology*; D007413:Intestinal Mucosa / Q000502:physiology; D007421:Intestine, Small; D015640:Ion Channel Gating / Q000187:drug effects; D008564:Membrane Potentials; D009337:Necturus; D011188:Potassium / Q000494:pharmacology; D026902:Potassium Channel Blockers; D012413:Rubidium / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology
D026902:Potassium Channel Blockers; D012964:Sodium; D012413:Rubidium; D002794:Choline; D011188:Potassium; D005905:Glyburide